What are the best treatments for Ehlers Danlos?

There is currently no cure for Ehlers-Danlos syndrome (EDS), so the best treatment approach focuses on multidisciplinary symptom management, physical therapy to stabilize joints, and proactive monitoring for complications.

First-Line and Non-Pharmacological Management

Because Ehlers-Danlos syndrome is a systemic connective tissue disorder, the cornerstone of care is conservative management. Physical therapy is the most critical intervention; it focuses on strengthening the muscles surrounding unstable joints (proprioceptive training) to compensate for ligamentous laxity. Occupational therapy is also vital, providing assistive devices, bracing, or splinting to reduce the daily strain on joints. Because Ehlers-Danlos syndrome affects patients differently, these therapies must be low-impact and tailored to individual tolerance.

Medications and Surgical Considerations

Pharmacological treatment for Ehlers-Danlos syndrome is strictly symptomatic. Physicians may prescribe non-steroidal anti-inflammatory drugs (NSAIDs) or acetaminophen for chronic pain, though long-term efficacy varies. In some cases, tricyclic antidepressants or gabapentin (Neurontin) are utilized for neuropathic pain. Surgical intervention is generally approached with extreme caution, as patients often experience poor wound healing and increased risk of tissue fragility, making surgery a last resort rather than a first-line treatment.

Building a Multidisciplinary Care Team

Managing the complexities of Ehlers-Danlos syndrome requires a coordinated team. Essential specialists typically include a physical therapist familiar with hypermobility, a cardiologist (to screen for vascular involvement or dysautonomia like POTS), a pain management specialist, and a geneticist for initial diagnosis and family planning. Research into collagen-strengthening therapies is ongoing, but currently, no disease-modifying drugs are approved, and clinical trials remain limited in scale.

Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding your specific medical condition, as treatment plans must be personalized by your medical team.

References

• NIH Genetic and Rare Diseases Information Center (GARD) - Ehlers-Danlos syndromes


• Orphanet: The portal for rare diseases and orphan drugs


• The Ehlers-Danlos Society: International Classification and Management Guidelines